These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

736 related articles for article (PubMed ID: 16051886)

  • 1. Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction.
    Schulze PC; Fang J; Kassik KA; Gannon J; Cupesi M; MacGillivray C; Lee RT; Rosenthal N
    Circ Res; 2005 Sep; 97(5):418-26. PubMed ID: 16051886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.
    Sandri M; Sandri C; Gilbert A; Skurk C; Calabria E; Picard A; Walsh K; Schiaffino S; Lecker SH; Goldberg AL
    Cell; 2004 Apr; 117(3):399-412. PubMed ID: 15109499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.
    Stitt TN; Drujan D; Clarke BA; Panaro F; Timofeyva Y; Kline WO; Gonzalez M; Yancopoulos GD; Glass DJ
    Mol Cell; 2004 May; 14(3):395-403. PubMed ID: 15125842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy.
    Glass DJ
    Nat Cell Biol; 2003 Feb; 5(2):87-90. PubMed ID: 12563267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromium supplement inhibits skeletal muscle atrophy in hindlimb-suspended mice.
    Dong F; Hua Y; Zhao P; Ren J; Du M; Sreejayan N
    J Nutr Biochem; 2009 Dec; 20(12):992-9. PubMed ID: 19071005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression.
    Yoshida T; Semprun-Prieto L; Sukhanov S; Delafontaine P
    Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1565-70. PubMed ID: 20228261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading.
    Nakao R; Hirasaka K; Goto J; Ishidoh K; Yamada C; Ohno A; Okumura Y; Nonaka I; Yasutomo K; Baldwin KM; Kominami E; Higashibata A; Nagano K; Tanaka K; Yasui N; Mills EM; Takeda S; Nikawa T
    Mol Cell Biol; 2009 Sep; 29(17):4798-811. PubMed ID: 19546233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486.
    Xu J; Li R; Workeneh B; Dong Y; Wang X; Hu Z
    Kidney Int; 2012 Aug; 82(4):401-11. PubMed ID: 22475820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle hypertrophy and atrophy signaling pathways.
    Glass DJ
    Int J Biochem Cell Biol; 2005 Oct; 37(10):1974-84. PubMed ID: 16087388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling pathways perturbing muscle mass.
    Glass DJ
    Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):225-9. PubMed ID: 20397318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signalling pathways regulating muscle mass in ageing skeletal muscle: the role of the IGF1-Akt-mTOR-FoxO pathway.
    Sandri M; Barberi L; Bijlsma AY; Blaauw B; Dyar KA; Milan G; Mammucari C; Meskers CG; Pallafacchina G; Paoli A; Pion D; Roceri M; Romanello V; Serrano AL; Toniolo L; Larsson L; Maier AB; Muñoz-Cánoves P; Musarò A; Pende M; Reggiani C; Rizzuto R; Schiaffino S
    Biogerontology; 2013 Jun; 14(3):303-23. PubMed ID: 23686362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.
    Gonçalves DA; Lira EC; Baviera AM; Cao P; Zanon NM; Arany Z; Bedard N; Tanksale P; Wing SS; Lecker SH; Kettelhut IC; Navegantes LC
    Endocrinology; 2009 Dec; 150(12):5395-404. PubMed ID: 19837877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3beta pathways and inhibition of atrogin-1 mRNA.
    Dehoux M; Gobier C; Lause P; Bertrand L; Ketelslegers JM; Thissen JP
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E145-50. PubMed ID: 16926385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
    Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
    Glass DJ
    Curr Top Microbiol Immunol; 2010; 346():267-78. PubMed ID: 20593312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting.
    Song YH; Li Y; Du J; Mitch WE; Rosenthal N; Delafontaine P
    J Clin Invest; 2005 Feb; 115(2):451-8. PubMed ID: 15650772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
    Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
    J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1.
    Léger B; Vergani L; Sorarù G; Hespel P; Derave W; Gobelet C; D'Ascenzio C; Angelini C; Russell AP
    FASEB J; 2006 Mar; 20(3):583-5. PubMed ID: 16507768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XIAP reduces muscle proteolysis induced by CKD.
    Hu J; Du J; Zhang L; Price SR; Klein JD; Wang XH
    J Am Soc Nephrol; 2010 Jul; 21(7):1174-83. PubMed ID: 20431038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas.
    Morales MG; Abrigo J; Acuña MJ; Santos RA; Bader M; Brandan E; Simon F; Olguin H; Cabrera D; Cabello-Verrugio C
    Dis Model Mech; 2016 Apr; 9(4):441-9. PubMed ID: 26851244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.